November 2020

This year, Deepbridge will be supporting #FootballShirtFriday!

On Friday 20th November, we urge you to wear your favourite football shirt, donate and share a selfie to raise vital funds that will go towards the Bobby Moore Fund's pioneering bowel cancer research.

Deepbridge are delighted to announce that we have been shortlisted for 4 awards at this year’s Growth Investor Awards, taking place in December 2020.

Zilico, which is part of the Deepbridge Life Sciences EIS portfolio, has announced that Bradford Teaching Hospitals NHS Foundation Trust has received funding from the Michelle Henderson Cervical Cancer Trust, allowing them to introduce ZedScan™ to aim to further improve the diagnosis of cervical cancer in women referred to its colposcopy clinics at Bradford Royal Infirmary.

Sky Medical Technology, which is part of the Deepbridge Technology Growth EIS portfolio, has been recognised as the 'Most Innovative MedTech Company' in the International Life Sciences Awards 2020.

This celebrates Sky Medical's contribution to the life sciences sector through the continues adoption of the geko™ device to aim to improve patient outcomes.

arbnco, which is part of the Deepbridge Technology Growth EIS, has been awarded Innovate UK funding to help households improve their air quality.

This competition is aiming to support the research and development of products and services which monitor a wide range of household pollutants. arbnco will bid for up to £300K for a 12-month phase 2 project to develop and test the solution.